A detailed history of 3 Chopt Investment Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, 3 Chopt Investment Partners, LLC holds 3,263 shares of LLY stock, worth $2.96 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
3,263
Previous 3,477 6.15%
Holding current value
$2.96 Million
Previous $2.03 Billion 25.25%
% of portfolio
1.04%
Previous 0.75%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $126,730 - $169,547
-214 Reduced 6.15%
3,263 $2.54 Billion
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $1.83 Million - $2.15 Million
3,477 New
3,477 $2.03 Billion
Q1 2023

May 22, 2023

BUY
$310.63 - $364.82 $729,359 - $856,597
2,348 New
2,348 $806 Million
Q4 2022

May 24, 2023

SELL
$321.55 - $374.67 $192,930 - $224,802
-600 Reduced 25.55%
1,748 $639 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $862B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track 3 Chopt Investment Partners, LLC Portfolio

Follow 3 Chopt Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 3 Chopt Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 3 Chopt Investment Partners, LLC with notifications on news.